These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9396424)
21. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Ueda M; Becker AE; Kasayuki N; Kojima A; Morita Y; Tanaka S Am J Pathol; 1996 Sep; 149(3):831-43. PubMed ID: 8780387 [TBL] [Abstract][Full Text] [Related]
22. Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty. Brozovich FV; Morganroth J; Gottlieb NB; Gottlieb RS Cathet Cardiovasc Diagn; 1991 Aug; 23(4):263-7. PubMed ID: 1653645 [TBL] [Abstract][Full Text] [Related]
23. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676 [TBL] [Abstract][Full Text] [Related]
24. Coronary angioplasty from the perspective of atherosclerotic plaque: morphologic predictors of immediate success and restenosis. Virmani R; Farb A; Burke AP Am Heart J; 1994 Jan; 127(1):163-79. PubMed ID: 8273736 [TBL] [Abstract][Full Text] [Related]
25. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568 [TBL] [Abstract][Full Text] [Related]
26. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty. Hokimoto S; Ogawa H; Saito T; Oshima S; Noda K; Soejima H; Takazoe K; Date H; Ishibashi F; Nakamura S; Yasue H Jpn Circ J; 2000 Nov; 64(11):831-4. PubMed ID: 11110426 [TBL] [Abstract][Full Text] [Related]
27. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty. Völzke H; Hertwig S; Rettig R; Motz W Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054 [TBL] [Abstract][Full Text] [Related]
28. Ace D/I polymorphism and incidence of post-PTCA restenosis: a prospective, angiography-based evaluation. Zee RY; Fernandez-Ortiz A; Macaya C; Pintor E; Lindpaintner K; Fernandez-Cruz A Hypertension; 2001 Mar; 37(3):851-5. PubMed ID: 11244007 [TBL] [Abstract][Full Text] [Related]
30. Localization of c-Myb and induction of apoptosis by antisense oligonucleotide c-Myb after angioplasty of porcine coronary arteries. Lambert DL; Malik N; Shepherd L; Gunn J; Francis SE; King A; Crossman DC; Cumberland DC; Holt CM Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1727-32. PubMed ID: 11701457 [TBL] [Abstract][Full Text] [Related]
31. Histopathology of postpercutaneous transluminal coronary angioplasty remodeling in human coronary arteries. Sangiorgi G; Taylor AJ; Farb A; Carter AJ; Edwards WD; Holmes DR; Schwartz RS; Virmani R Am Heart J; 1999 Oct; 138(4 Pt 1):681-7. PubMed ID: 10502214 [TBL] [Abstract][Full Text] [Related]
32. Restenosis after percutaneous transluminal coronary angioplasty--a histopathological study using autopsied hearts. Morimoto S; Mizuno Y; Hiramitsu S; Yamada K; Kubo N; Nomura M; Yamaguchi T; Kitazume H; Kodama K; Kurogane H Jpn Circ J; 1990 Jan; 54(1):43-56. PubMed ID: 2332932 [TBL] [Abstract][Full Text] [Related]